{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T06:45:51Z","timestamp":1775630751793,"version":"3.50.1"},"reference-count":87,"publisher":"Media Sphere Publishing House","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rus. J. Cardio. Cardiovas. Surg."],"published-print":{"date-parts":[[2026,4,8]]},"abstract":"<jats:p>Relevance. Cardiovascular diseases (CVDs) remain one of the leading causes of mortality worldwide. In recent years, significant attention has been given to L-arginine, a conditionally essential amino acid that serves as a key precursor of nitric oxide, a critically important mediator of vascular function. Dysregulation of L-arginine metabolism and the development of endothelial dysfunction play a significant pathogenetic role in the development and progression of CVDs. Objective. This review aims to systematize current data on the role of L-arginine in the regulation of vascular tone, its impact on endothelium-dependent vasodilation, and to assess the potential application of L-arginine in the intensive care of cardiovascular diseases. Material and methods. A comprehensive analysis of the results of in vitro and in vivo experimental studies, as well as clinical trials focused on examining the influence of L-arginine on endothelial function, hemodynamic parameters, coronary blood flow, and other cardiovascular system parameters was conducted. Particular attention was given to analyzing the molecular mechanisms of NO-mediated action of L-arginine and its interaction with the arginase enzyme. Results. L-arginine contributes to enhancing endothelium-dependent vasodilation, reducing blood pressure, and can have a positive impact in cases of coronary heart disease, heart failure, and atherosclerosis. It is important to note that the effectiveness of L-arginine therapy can be modulated by the level of ADMA, an endogenous inhibitor of nitric oxide synthase (NOS). Conclusion. L-arginine represents a promising therapeutic agent for use in the intensive care of CVDs, especially in patients facing potential ischemia-reperfusion syndrome. To determine optimal therapeutic strategies, including dosage selection and identification of target patient groups, further large-scale, placebo-controlled clinical studies are necessary.<\/jats:p>","DOI":"10.17116\/kardio20261902175","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:45:46Z","timestamp":1775627146000},"page":"75","source":"Crossref","is-referenced-by-count":0,"title":["L-Arginine as a New Tool in the Intensive Care of Cardiovascular Disorders: Review"],"prefix":"10.17116","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2537-0142","authenticated-orcid":false,"given":"I.S.","family":"Simutis","sequence":"first","affiliation":[{"name":"North-Western District Scientific and Clinical Center Named after L. G. Sokolov of the Federal Medical and Biological Agency","place":["St. Petersburg, Russia"]},{"name":"North-Western State Medical University named after I.I. Mechnikov","place":["St. Petersburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4168-1853","authenticated-orcid":false,"given":"N.Yu.","family":"Semigolovskii","sequence":"additional","affiliation":[{"name":"North-Western District Scientific and Clinical Center Named after L. G. Sokolov of the Federal Medical and Biological Agency","place":["St. Petersburg, Russia"]},{"name":"Sankt-Petersburg State University","place":["St. Petersburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5787-9115","authenticated-orcid":false,"given":"I.G.","family":"Lobachenko","sequence":"additional","affiliation":[{"name":"North-Western District Scientific and Clinical Center Named after L. G. Sokolov of the Federal Medical and Biological Agency","place":["St. Petersburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6433-2659","authenticated-orcid":false,"given":"A.A.","family":"Sapegin","sequence":"additional","affiliation":[{"name":"North-Western District Scientific and Clinical Center Named after L. G. Sokolov of the Federal Medical and Biological Agency","place":["St. Petersburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5961-7433","authenticated-orcid":false,"given":"M.S.","family":"Danilov","sequence":"additional","affiliation":[{"name":"North-Western District Scientific and Clinical Center Named after L. G. Sokolov of the Federal Medical and Biological Agency","place":["St. Petersburg, Russia"]},{"name":"North-Western State Medical University named after I.I. Mechnikov","place":["St. Petersburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4716-0314","authenticated-orcid":false,"given":"E.S.","family":"Iusupov","sequence":"additional","affiliation":[{"name":"North-Western District Scientific and Clinical Center Named after L. G. Sokolov of the Federal Medical and Biological Agency","place":["St. Petersburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.N.","family":"Enkina","sequence":"additional","affiliation":[{"name":"North-Western District Scientific and Clinical Center Named after L. G. Sokolov of the Federal Medical and Biological Agency","place":["St. Petersburg, Russia"]},{"name":"Medical Academy named after F.I. Inozemtsev","place":["St. Petersburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2347-0123","authenticated-orcid":false,"given":"K.","family":"Blitsyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6520-9399","authenticated-orcid":false,"given":"I.E.","family":"Karpov","sequence":"additional","affiliation":[{"name":"North-Western State Medical University named after I.I. Mechnikov","place":["St. Petersburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0183-8166","authenticated-orcid":false,"given":"I.V.","family":"Suvorova","sequence":"additional","affiliation":[{"name":"North-Western District Scientific and Clinical Center Named after L. G. Sokolov of the Federal Medical and Biological Agency","place":["St. Petersburg, Russia"]},{"name":"Almazov National Medical Research Center","place":["St. Petersburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/kardio20261902175-1","doi-asserted-by":"publisher","DOI":"10.1191\/1358863\u00d702vm434ra"},{"key":"key-10.17116\/kardio20261902175-2","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/134.10.2842S."},{"key":"key-10.17116\/kardio20261902175-3","doi-asserted-by":"crossref","unstructured":"Vallance P, Leone A, Calver A, Collier J, Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol. 1992;20(Suppl 12):S60-S62","DOI":"10.1097\/00005344-199204002-00018"},{"key":"key-10.17116\/kardio20261902175-4","doi-asserted-by":"crossref","unstructured":"Chatterjee A, Catravas JD. Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vascul Pharmacol. 2008;49(4-6): 134-140","DOI":"10.1016\/j.vph.2008.06.008"},{"key":"key-10.17116\/kardio20261902175-5","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8080277"},{"key":"key-10.17116\/kardio20261902175-6","doi-asserted-by":"publisher","DOI":"10.1191\/1358863\u00d702vm434ra"},{"key":"key-10.17116\/kardio20261902175-7","unstructured":"Golovchenko YuI, Treshchinskaya MA. Review of modern concepts of endothelial dysfunction. Consilium Medicum Ukraina. 2008;(11):38-40. (In Russ.)"},{"key":"key-10.17116\/kardio20261902175-8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.569914"},{"key":"key-10.17116\/kardio20261902175-9","doi-asserted-by":"publisher","DOI":"10.1038\/288373a0"},{"key":"key-10.17116\/kardio20261902175-10","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00927.2012"},{"key":"key-10.17116\/kardio20261902175-11","unstructured":"Markov KhM. L-arginine \u2014 nitric oxide in the treatment of cardiovascular diseases. Cardiology. 2005;6:87-95. (In Russ.)"},{"key":"key-10.17116\/kardio20261902175-12","unstructured":"Sosunov AA. Nitric oxide as an intercellular mediator. Soros Educational Journal. 2000;6(12):27-34. (In Russ.)"},{"key":"key-10.17116\/kardio20261902175-13","doi-asserted-by":"publisher","DOI":"10.1067\/mva.2000.103788"},{"key":"key-10.17116\/kardio20261902175-14","doi-asserted-by":"crossref","unstructured":"Pernow J, Jung C. Arginase as a potential target in the treatment of cardiovascular disease: Reversal of arginine steal? Cardiovasc Res. 2013;98:334-343","DOI":"10.1093\/cvr\/cvt036"},{"key":"key-10.17116\/kardio20261902175-15","doi-asserted-by":"crossref","unstructured":"Pandey D, Romer L, Berkowitz DE. Arginase II: Atherogenesis beyond enzyme activity. J Am Heart Assoc. 2013;2:e000392","DOI":"10.1161\/JAHA.113.000392"},{"key":"key-10.17116\/kardio20261902175-16","doi-asserted-by":"publisher","DOI":"10.1016\/0305-0491(95)02138-8"},{"key":"key-10.17116\/kardio20261902175-17","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2004.05.004"},{"key":"key-10.17116\/kardio20261902175-18","doi-asserted-by":"crossref","unstructured":"Romero MJ, Platt DH. Tawfik HE. Labazi M, El-Remessy AB, Bartoli M, Caldwell RB, Caldwell RW. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res. 2008;102:95-102","DOI":"10.1161\/CIRCRESAHA.107.155028"},{"key":"key-10.17116\/kardio20261902175-19","doi-asserted-by":"publisher","DOI":"10.1096\/fj.03-0115fje"},{"key":"key-10.17116\/kardio20261902175-20","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.2001.280.1.E75"},{"key":"key-10.17116\/kardio20261902175-21","doi-asserted-by":"crossref","unstructured":"Shemyakin A, Kovamees O, Rafnsson A, Bohm F, Svenarud P, Settergren M, Jung C, Pernow J. Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus. Circulation 2012;126:2943-2950","DOI":"10.1161\/CIRCULATIONAHA.112.140335"},{"key":"key-10.17116\/kardio20261902175-22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103260"},{"key":"key-10.17116\/kardio20261902175-23","doi-asserted-by":"crossref","unstructured":"Teupser D, Burkhardt R, Wilfert W, Haffner I, Nebendahl K, Thiery J. Identification of macrophage arginase I as a new candidate gene of atherosclerosis resistance. Arterioscler Thromb Vasc Biol. 2006;26:365-371","DOI":"10.1161\/01.ATV.0000195791.83380.4c"},{"key":"key-10.17116\/kardio20261902175-24","doi-asserted-by":"crossref","unstructured":"Katusic ZS. Mechanisms of endothelial dysfunction induced by aging: Role of arginase I. Circ Res. 2007;101:640-641","DOI":"10.1161\/CIRCRESAHA.107.162701"},{"key":"key-10.17116\/kardio20261902175-25","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1992.262.4.H1211"},{"key":"key-10.17116\/kardio20261902175-26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.6.2106"},{"key":"key-10.17116\/kardio20261902175-27","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa003"},{"key":"key-10.17116\/kardio20261902175-28","doi-asserted-by":"publisher","DOI":"10.1038\/ncpcardio0878"},{"key":"key-10.17116\/kardio20261902175-29","doi-asserted-by":"crossref","unstructured":"Berkowitz DE, White R, Li, D, Minhas KM, Cernetich A, Kim S, Burke S, Shoukas AA, Nyhan D, Champion HC. ea. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation. 2003;108:2000-2006","DOI":"10.1161\/01.CIR.0000092948.04444.C7"},{"key":"key-10.17116\/kardio20261902175-30","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(98)00323-4"},{"key":"key-10.17116\/kardio20261902175-31","doi-asserted-by":"publisher","DOI":"10.1016\/s0049-3848(97)00106-0"},{"key":"key-10.17116\/kardio20261902175-32","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2000.2344"},{"key":"key-10.17116\/kardio20261902175-33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212364"},{"key":"key-10.17116\/kardio20261902175-34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2011.09.012"},{"key":"key-10.17116\/kardio20261902175-35","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.33.41"},{"key":"key-10.17116\/kardio20261902175-36","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.80.7.7608279"},{"key":"key-10.17116\/kardio20261902175-37","doi-asserted-by":"publisher","DOI":"10.3109\/14767051003677962"},{"key":"key-10.17116\/kardio20261902175-38","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-020-00601-9"},{"key":"key-10.17116\/kardio20261902175-39","doi-asserted-by":"publisher","DOI":"10.1126\/science.7123259"},{"key":"key-10.17116\/kardio20261902175-40","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm_00000384"},{"key":"key-10.17116\/kardio20261902175-41","doi-asserted-by":"crossref","unstructured":"Padilla F, Garcia-Dorado D, Agullo L, Inserte J, Paniagua A, Mirabet S, Barrabes JA, Ruiz-Meana M, Soler-Soler J. L-Arginine administration prevents reperfusion-induced cardiomyocyte hypercontracture and reduces infarct size in the pig. Cardiovasc Res. 2000;46:412-420","DOI":"10.1016\/S0008-6363(00)00048-1"},{"key":"key-10.17116\/kardio20261902175-42","doi-asserted-by":"crossref","unstructured":"Adams MR, McCredie R, Jessup W, Robinson J, Sullivan D, Celermajer DS. Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease. Atherosclerosis. 1997;129:261-269","DOI":"10.1016\/S0021-9150(96)06044-3"},{"key":"key-10.17116\/kardio20261902175-43","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.1.58"},{"key":"key-10.17116\/kardio20261902175-44","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(97)00354-8"},{"key":"key-10.17116\/kardio20261902175-45","doi-asserted-by":"crossref","unstructured":"Walker HA, McGing E, Fisher I, Boger RH, Bode-Boger SM, Jackson G, Ritter JM, Chowienczyk PJ. Endothelium-dependent vasodilation is independent of the plasma L-arginine\/ADMA ratio in men with stable angina: Lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance. J Am Coll Cardiol. 2001;38:499-505","DOI":"10.1016\/S0735-1097(01)01380-8"},{"key":"key-10.17116\/kardio20261902175-46","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.81.5.505"},{"key":"key-10.17116\/kardio20261902175-47","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)90760-v"},{"key":"key-10.17116\/kardio20261902175-48","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.94.2.130"},{"key":"key-10.17116\/kardio20261902175-49","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(97)00279-9"},{"key":"key-10.17116\/kardio20261902175-50","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.97.21.2123"},{"key":"key-10.17116\/kardio20261902175-51","doi-asserted-by":"crossref","unstructured":"Yin W-H, Chen J-W, Tsai C, Chiang M-C, Young MS, Lin S-J. L-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease. Clin Nutr. 2005 Dec;24(6):988-997","DOI":"10.1016\/j.clnu.2005.07.003"},{"key":"key-10.17116\/kardio20261902175-52","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.19.3.76"},{"key":"key-10.17116\/kardio20261902175-53","unstructured":"Shiraki T, Takamura T, Kajiyama A, Oka T, Saito D. Effect of short-term administration of high dose L-arginine on restenosis after percutaneous transluminal coronary angioplasty. J Cardiol. 2004;44(1):13-20. PMID: 15334880"},{"key":"key-10.17116\/kardio20261902175-54","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(01)02252-4"},{"key":"key-10.17116\/kardio20261902175-55","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-024-04318-8"},{"key":"key-10.17116\/kardio20261902175-56","doi-asserted-by":"crossref","unstructured":"Doutreleau S, Mettauer B, Piquard F, Rouyer O, Schaefer A, Lonsdorfer J, Geny B. Chronic L-arginine supplementation enhances endurance exercise tolerance in heart failure patients. Int J Sports Med. 2006;27:567-572","DOI":"10.1055\/s-2005-865847"},{"key":"key-10.17116\/kardio20261902175-57","doi-asserted-by":"crossref","unstructured":"Chin-Dusting JP, Kaye DM, Lefkovits J, Wong J, Bergin P, Jennings GL. Dietary supplementation with L-arginine fails to restore endothelial function in forearm resistance arteries of patients with severe heart failure. J Am Coll Cardiol. 1996;27:1207-1213","DOI":"10.1016\/0735-1097(95)00611-7"},{"key":"key-10.17116\/kardio20261902175-58","doi-asserted-by":"crossref","unstructured":"Wilson AM, Harada R, Nair N, Balasubramanian N, Cooke JP. L-arginine supplementation in peripheral arterial disease: No benefit and possible harm. Circulation. 2007;116:188-195","DOI":"10.1161\/CIRCULATIONAHA.106.683656"},{"key":"key-10.17116\/kardio20261902175-59","doi-asserted-by":"crossref","unstructured":"Blum A, Hathaway L, Mincemoyer R, Schenke WH, Kirby M, Csako G, Waclawiw MA, Panza JA, Cannon RO, III. Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women. J Am Coll Cardiol. 2000;35:271-276","DOI":"10.1016\/S0735-1097(99)00553-7"},{"key":"key-10.17116\/kardio20261902175-60","doi-asserted-by":"crossref","unstructured":"Deveaux A, Fouillet H, Petzke KJ, Hermier D, Andre E, Bunouf P, Lantoine-Adam F, Benamouzig R, Mathe V, Huneau JF, et al. A Slow-Compared with a Fast-Release Form of Oral Arginine Increases Its Utilization for Nitric Oxide Synthesis in Overweight Adults with Cardiometabolic Risk Factors in a Randomized Controlled Study. J Nutr. 2016;146:1322-1329","DOI":"10.3945\/jn.116.231910"},{"key":"key-10.17116\/kardio20261902175-61","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-023-03354-6"},{"key":"key-10.17116\/kardio20261902175-62","doi-asserted-by":"publisher","DOI":"10.3945\/jn.115.228478"},{"key":"key-10.17116\/kardio20261902175-63","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-015-2031-0"},{"key":"key-10.17116\/kardio20261902175-64","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014"},{"key":"key-10.17116\/kardio20261902175-65","doi-asserted-by":"publisher","DOI":"10.1177\/1358836X0501000104"},{"key":"key-10.17116\/kardio20261902175-66","doi-asserted-by":"crossref","unstructured":"Dioguardi FS. To give or not to give? Lessons from the arginine paradox. J Nutrigenet Nutrige. 2011;4:90-98","DOI":"10.1159\/000327777"},{"key":"key-10.17116\/kardio20261902175-67","doi-asserted-by":"crossref","unstructured":"Bartnicki P, Kowalczyk M, Franczyk-Skora B, Baj Z, Rysz J. Evaluation of Endothelial (dys)Function, Left Ventricular Structure and Function in Patients with Chronic Kidney Disease. Curr Vasc Pharmacol. 2016;14:360-367","DOI":"10.2174\/1570161114666160112142403"},{"key":"key-10.17116\/kardio20261902175-68","doi-asserted-by":"crossref","unstructured":"Janes F, Cifu A, Pessa ME, Domenis R, Gigli GL, Sanvilli N, Nilo A, Garbo R, Curcio F, Giacomello R, et al. ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease. Sci Rep. 2019;9:14207","DOI":"10.1038\/s41598-019-50778-w"},{"key":"key-10.17116\/kardio20261902175-69","doi-asserted-by":"crossref","unstructured":"Wijnands KA, Hoeksema MA, Meesters DM, van den Akker NM, Molin DG, Briede JJ, Ghosh M, Kohler SE, van Zandvoort MA, de Winther MP, et al. Arginase-1 deficiency regulates arginine concentrations and NOS2-mediated NO production during endotoxemia. PLoS One. 2014;9:e86135","DOI":"10.1371\/journal.pone.0086135"},{"key":"key-10.17116\/kardio20261902175-70","doi-asserted-by":"crossref","unstructured":"Chirinos JA, David R, Bralley JA, Zea-Diaz H, Munoz-Atahualpa E, Corrales-Medina F, Cuba-Bustinza C, Chirinos-Pacheco J, Medina-Lezama J. Endogenous nitric oxide synthase inhibitors, arterial hemodynamics, and subclinical vascular disease: The Prevencion Study. Hypertension. 2008;52","DOI":"10.1161\/HYPERTENSIONAHA.108.120352"},{"key":"key-10.17116\/kardio20261902175-71","doi-asserted-by":"crossref","unstructured":"Abedini S, Meinitzer A, Holme I, Marz W, Weihrauch G, Fellstrom B, Jardine A, Holdaas H. Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients. Kidney Int. 2010;77:44-50","DOI":"10.1038\/ki.2009.382"},{"key":"key-10.17116\/kardio20261902175-72","doi-asserted-by":"crossref","unstructured":"Nanayakkara PW, Teerlink T, Stehouwer CD, Allajar D, Spijkerman A, Schalkwijk C, ter Wee PM,van Guldener C. Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure. Kidney Int. 2005;68:2230-2236","DOI":"10.1111\/j.1523-1755.2005.00680.x"},{"key":"key-10.17116\/kardio20261902175-73","doi-asserted-by":"crossref","unstructured":"Furuki K, Adachi H, Matsuoka H, Enomoto M, Satoh A, Hino A, Hirai Y. Imaizumi T. Plasma levels of asymmetric dimethylarginine (ADMA) are related to intima-media thickness of the carotid artery: An epidemiological study. Atherosclerosis. 2007;191:206-210","DOI":"10.1016\/j.atherosclerosis.2006.03.022"},{"key":"key-10.17116\/kardio20261902175-74","doi-asserted-by":"crossref","unstructured":"Maas R, Xanthakis V, Polak JF, Schwedhelm E, Sullivan LM, Benndorf R, Schulze F, Vasan RS, Wolf PA, B\u00f6ger RH, Seshadri S. Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort. Stroke. 2009;40:2715-2719","DOI":"10.1161\/STROKEAHA.109.552539"},{"key":"key-10.17116\/kardio20261902175-75","doi-asserted-by":"crossref","unstructured":"Bai Y, Sun L, Du L, Zhang T, Xin W, Lan X, Du G. Association of circulating levels of asymmetric dimethylarginine (ADMA) with carotid intima-media thickness: Evidence from 6168 participants. Ageing Res Rev. 2013;12:699-707","DOI":"10.1016\/j.arr.2012.02.003"},{"key":"key-10.17116\/kardio20261902175-76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.06.254"},{"key":"key-10.17116\/kardio20261902175-77","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.001833"},{"key":"key-10.17116\/kardio20261902175-78","doi-asserted-by":"publisher","DOI":"10.2174\/0929867322666150625095046"},{"key":"key-10.17116\/kardio20261902175-79","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960261006"},{"key":"key-10.17116\/kardio20261902175-80","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-12-145"},{"key":"key-10.17116\/kardio20261902175-81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2006.06.005"},{"key":"key-10.17116\/kardio20261902175-82","doi-asserted-by":"publisher","DOI":"10.1159\/000337485"},{"key":"key-10.17116\/kardio20261902175-83","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2017.06.036"},{"key":"key-10.17116\/kardio20261902175-84","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm_00000176"},{"key":"key-10.17116\/kardio20261902175-85","doi-asserted-by":"crossref","unstructured":"Notsu Y, Yano S, Shibata H, Nagai A, Nabika T. Plasma arginine\/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study. Atherosclerosis. 2015;239:61-66","DOI":"10.1016\/j.atherosclerosis.2014.12.030"},{"key":"key-10.17116\/kardio20261902175-86","doi-asserted-by":"crossref","unstructured":"Boger RH, Endres HG, Schwedhelm E, Darius H, Atzler D, Luneburg N, von Stritzky B, Maas R, Thiem U, Benndorf RA, et al. Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease. J Intern Med. 2011;269:349-361","DOI":"10.1111\/j.1365-2796.2010.02322.x"},{"key":"key-10.17116\/kardio20261902175-87","doi-asserted-by":"crossref","unstructured":"Pizzarelli F, Maas R, Dattolo P, Tripepi G, Michelassi S, D\u2019Arrigo G, Mieth M, Bandinelli S, Ferrucci L, Zoccali C. Asymmetric dimethylarginine predicts survival in the elderly. Age. 2013;35: 2465-2475","DOI":"10.1007\/s11357-013-9523-1"}],"container-title":["Russian Journal of Cardiology and Cardiovascular Surgery"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:46:36Z","timestamp":1775627196000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/kardiologiya-i-serdechno-sosudistaya-khirurgiya\/2026\/2\/1199663852026021075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4,8]]}},"alternative-id":["10.17116\/kardio20261902175"],"URL":"https:\/\/doi.org\/10.17116\/kardio20261902175","relation":{},"ISSN":["1996-6385"],"issn-type":[{"value":"1996-6385","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,8]]}}}